This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Luigi Caliendo explains the benefits of Robotic Technology to President Vincenzo de Luca. Luigi Caliendo explains the benefits of Robotic Technology to President Vincenzo de Luca. When left untreated, arrhythmias may significantly increase the risk of stroke , heart failure , and sudden cardiac arrest. "The
The HeartRhythm Society (HRS) is preparing for HRX 2024, the third annual event of its kind, which will be held from September 5-7, 2024, in Atlanta, GA, gathering cardiovascular health innovators together to explore discoveries and advance partnerships between medicine and technology. Avari Silva On Saturday, Sept.
These reductions in cost and carbon emissions will help shape conversations around the value of medical technology re-use at the annual HeartRhythm Society conference in Boston. I am hopeful that HeartRhythm Society’s conference will reflect this.” electrophysiology labs.
milla1cf Thu, 05/30/2024 - 10:31 May 30, 2024 — Stereotaxis , a pioneer in surgical robotics for minimally invasive endovascular intervention, announced the successful treatment of the first heartrhythm patients by Penn Presbyterian Medical Center (PPMC) utilizing the advanced Genesis Robotic Magnetic Navigation System.
The robotic technology represented an entirely novel way to address heartrhythm disorders in a minimally invasive procedure with the benefits of robotic precision and safety. When left untreated, arrhythmias may significantly increase the risk of stroke, heart failure, and sudden cardiac arrest.
It is exciting to see the convergence of our pioneering work in artificial intelligence and remote patient monitoring through this new partnership between Anumana and InfoBionic.Ai,” said Peter Noseworthy, MD, chair of the HeartRhythm Services Division of Cardiovascular Medicine at Mayo and a board director at InfoBionic.Ai. “By
In the age of technology, wearable devices have revolutionized how we approach health and wellness. Among their many benefits, wearable tech has proven to be a game-changer in monitoring heart health, particularly for individuals managing cardiovascular conditions or preparing for minimally invasive or bloodless heart surgery.
mtaschetta-millane Tue, 07/16/2024 - 09:47 July 16, 2024 — Ultrahuman, a pioneer in wearable technology , launches PowerPlugs, a platform for individual apps and plugins built on top of Ultrahuman’s health and wellness data stack. AFib is the most common type of irregular heartrhythm or arrhythmia.
To diagnose heart conditions including heart attacks and heartrhythm disturbances, clinicians typically rely on 12-lead electrocardiograms (ECGs) -- complex arrangements of electrodes and wires placed around the chest and limbs to detect the heart's electrical activity.
tim.hodson Mon, 04/21/2025 - 11:18 April 21, 2025 Stereotaxis, a provider of surgical robotics for minimally invasive endovascular intervention, will host a live demonstration of the GenesisX Robotic System at this years HeartRhythm Symposium (HRS), taking place April 24-27 in San Diego, CA.
milla1cf Fri, 05/10/2024 - 08:17 May 10, 2024 — With cardiovascular disease being a leading cause of mortality worldwide, Vivalink , a leading provider of digital healthcare solutions, announces the launch of its comprehensive technology solution designed for Mobile Cardiac Telemetry (MCT) and Holter monitoring.
Wearable technology has become increasingly prevalent. As technology rapidly advances, devices will ideally become more convenient and affordable, and their presence will become ubiquitous in the homes of all of our patients.
a medical technology company focused on transforming cardiac care through the power of personalized insights, today announced new study data demonstrating that HeartBeam AI combined with vectorcardiography (VCG) outperformed an expert panel of heartrhythm cardiologists in detecting atrial flutter.
care pathways and to provide millions of Americans with the ability to just use their smartphone to obtain easy and accurate heartrhythm measurements. These measurements can enable the early detection and monitoring of heartrhythm conditions such as atrial fibrillation. and a specificity of 99.9%.1
electrophysiology labs, and will be participating in the HeartRhythm Society annual meeting, HRS 2024, May 16-19 in Boston, MA. electrophysiology labs, and will be participating in the HeartRhythm Society annual meeting, HRS 2024, May 16-19 in Boston, MA. Innovative Health, Inc. electrophysiology labs.
milla1cf Tue, 05/21/2024 - 08:00 May 21, 2024 — Stereotaxis , a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has been invited to present at HRS Africa Summit 2024 , scheduled to take place during HeartRhythm Society Scientific Sessions in Boston, Massachusetts.
The data was presented by Vivek Reddy , MD, Director of Cardiac Arrhythmia Services at The Mount Sinai Hospital , during the European HeartRhythm Association (EHRA) conference in Berlin, Germany. The technology is designed to be used in HeartBeam’s small, portable, patient-friendly devices that allow for remote cardiac monitoring.
Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment 5. Scientists Suggest a New Method for Diagnosing Heart Diseases 6. Weight Loss Drug Linked with Reduced Need for Diuretics in Heart Failure Patients 7.
milla1cf Fri, 05/17/2024 - 18:54 May 17, 2024 — Royal Philips , a global leader in health technology, is presenting new retrospective study results demonstrating the clinical and economic benefits of Philips’ AI-powered cardiac care solutions at the HeartRhythm Annual Meeting in Boston (May 16-19).
iRhythm Technologies Receives European Union’s CE Marking Under Medical Device Regulation (EU MDR) for its Zio monitor and ZEUS System 3. UH Harrington Heart and Vascular Institute First in World to Implant Penditure Clip Using Minimally Invasive Approach 10.
Atrial fibrillation (AFib) is a common heartrhythm disorder characterized by an irregular and often rapid heartbeat. This condition can lead to various complications, including stroke and heart failure, making it essential to understand its causes, symptoms, and AFib treatment options.
Smart technologies such as smartphones and smartwatches used in everyday life offer promising avenues for enhancing AF management. Devices generate a myriad of health metrics that are constantly collected and readily available including heart rate, heartrhythm, and physical activity levels.
a medical technology company focused on transforming cardiac care through the power of personalized insights, announced significant developments for the use of artificial intelligence (AI) applied to its proprietary vectorelectrocardiography (VECG) technology, including the addition of new leadership and advisory roles.
Innovation in medical technology exists to improve patient outcomes, increase surgical efficiency and enhance patient safety. Infrequently, we see medical technology innovation of a paradigmatic nature that changes the way physicians approach disease states and dramatically improve results. So, again, innovation is great.
Kansas City HeartRhythm Institute at HCA Midwest Health, who served as principal investigator for the Amulet IDE trial. The Amplatzer Amulet redefined LAA closure by offering dual-seal technology that completely and immediately seals the LAA without requiring blood-thinning medication following the procedure.
UC San Diego Health is the first in San Diego to successfully implant the world’s first dual chamber and leadless pacemaker system to help treat people with abnormal heartrhythms. The burst of energy can cause the heart to beat more quickly (in a pacemaker), or it can stop dangerous rapid heartrhythms (in an ICD).
However, few technologies are currently available to automatically calculate fetal cardiac time intervals (CTIs). The motion relationship and time intervals of the pulsed-wave Doppler (PWD) spectrum are essential for diagnosing fetal arrhythmia (FA).
However, there is currently no commercially available cell source to apply this technology in the context of the cardiac conduction system (CCS). Methods The Microelectrode Array (MEA) system may be a suitable option, as it provides both real-time and non-invasive monitoring of cellular networks of spontaneously active cells.
"Tricuspid regurgitation can put added strain on the heart and lead to other cardiovascular issues, which can significantly worsen a person's quality of life, but historically there have been few treatment options," said Lars Søndergaard , M.D., On the final question of the benefit of TriClip versus the risk, the vote was 13 to 1 in favor.
Atrial fibrillation (AF) is the most common arrhythmia worldwide, with increasing prevalence resulting from improved awareness, increased life expectancy, and advances in detection technology.
will have AF, an irregular and potentially dangerous heartrhythm. chief medical officer of the Cardiac Rhythm Management business, which is part of the Cardiovascular Portfolio at Medtronic. The results were presented at the AF Symposium 2025. By 2030, approximately 12.2 million people in the U.S.
He was a dear friend and colleague of the HeartRhythm Society and electrophysiologists around the world. In this manner, David ushered in many ablation technologies and quickly became an icon for ablation trials, both preclinical and clinical, and taught us about best practices.
In the written statement, he added, "A high bar has been set by performance of the system in clinical and commercial settings – where more than 40,000 patients have been treated to date – and we look forward to continuing to lead the way with this differentiated technology in the growing PFA space."
In a world where technology reigns supreme, one of the most profound tools in medicine remains the irreplaceable electrocardiogram (ECG). It can measure many aspects, from how fast the heart beats to how well its chambers conduct electrical energy. Sinus tachycardia – sinus rhythm above 100 bpm is a sinus tachycardia.
New technologies Today, there are modern technologies available, which can improve the quality of ECG signals. Artificial intelligence (AI) technologies, such as machine learning and deep neural networks, are increasingly being used to analyze ECG signals. 50/60Hz waves from the electrical grid, artifacts).
Adamson, MD, MSc, FACC, FESC, FRCP (Ed) here Related Barostim content: Totality of Evidence from BeAT-HF Study Shows CVRx’s Barostim Provides Long-term Benefits for Patients with Heart Failure CVRx Reports Preliminary Results of the BeAT-HF Post-Market Randomized Clinical Trial Allegheny Health Network Cardiovascular Institute First in Pittsburgh to (..)
Cardiomatics is thrilled to announce a groundbreaking partnership with BIOTRONIK, a leading global medical technology company specialising in heart and blood vessel diseases as well as chronic pain. “BIOTRONIK is one of the leading companies in the cardiac rhythm management devices market.
5 Catheter ablation is a safe and effective procedure when drugs don't work to help restore the heart's incorrect electrical signals, which causes an abnormal heartrhythm.6 2,3 Approximately 1 in 4 adults over the age of 40 are at risk for developing AFib.4 1 These included one pseudoaneurysm, one PV stenosis and one hematoma.1
Heart rate (HR) is closely related to heartrhythm patterns, and its irregularity can imply serious health problems. We conclude the review with a discussion of challenges and future directions for the application of GCG technology. Therefore, HR is used in the diagnosis of many health conditions.
Early treatment of persistent AF can reduce the risk of blood clots, stroke, and heart failure, and may prevent the disease from becoming permanent. Patients are often treated with AADs as frontline therapy for heartrhythm maintenance, though some can experience adverse effects and limited efficacy. Circulation.
We now have one more technology, on the verge of approval by the FDA. Final message WiSE CRT uses some revolutionary technology and it is a welcome addition in few eligible patients. However, advanced heart failure therapy never means it can be achieved only by state-of-the-art technology. HeartRhythm.
Here, we will delve into the fascinating evolution of ECG technology, exploring its origins, key milestones, and modern applications. Image source: sciencedirect.org Revolution of ECG for Better Cardiac Health Throughout the 20th century, significant milestones in electrocardiogram technology shaped its development and widespread adoption.
How to Incorporate Remote Patient Monitoring Into Existing Workflows Remote patient monitoring (RPM) is a service under the telemedicine umbrella that uses specialized technology to track patient health data in real time, integrating care updates into clinic workflows as needed. The benefits of the technology are clear.
WHAT IT DOES An Apple Watch with the A-Fib feature uses an optical heart sensor to occasionally check a user's heartrhythm. It alerts the user with a notification if an irregular rhythm is detected on five rhythm checks over a minimum of 65 minutes. MARKET SNAPSHOT Apple was the first to launch an ECG app in 2018.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content